Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer

Clinical trial NCT01750073 · COMPLETED

Trial details

NCT number: NCT01750073
Sponsor: University of Nebraska
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Estrogen Receptor Negative Estrogen Receptor Positive HER2/Neu Negative HER2/Neu Positive Invasive Breast Carcinoma Progesterone Receptor Negative Progesterone Receptor Positive Stage IA Breast Cancer Stage II Breast Cancer Stage IIA Breast Cancer Stage IIB Breast Cancer Stage III Breast Cancer

Start date: 2012-12-07
Primary completion: 2022-05-01
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.